Form 8-K - Current report:
SEC Accession No. 0001193125-20-269801
Filing Date
2020-10-15
Accepted
2020-10-15 07:18:56
Documents
17
Period of Report
2020-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d102302d8k.htm   iXBRL 8-K 41004
2 EX-3.1 d102302dex31.htm EX-3.1 89973
3 EX-10.1 d102302dex101.htm EX-10.1 51335
4 EX-10.2 d102302dex102.htm EX-10.2 71281
5 EX-99.1 d102302dex991.htm EX-99.1 21128
9 GRAPHIC g102302g1015052938193.jpg GRAPHIC 4104
  Complete submission text file 0001193125-20-269801.txt   473955

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20201009.xsd EX-101.SCH 3094
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20201009_lab.xml EX-101.LAB 18125
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20201009_pre.xml EX-101.PRE 11421
10 EXTRACTED XBRL INSTANCE DOCUMENT d102302d8k_htm.xml XML 3481
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 201240313
SIC: 2835 In Vitro & In Vivo Diagnostic Substances